Home/Enthera Pharmaceuticals/Filippo Canducci, MD, PhD, MBA
FC

Filippo Canducci, MD, PhD, MBA

Chief Medical Officer

Enthera Pharmaceuticals

Enthera Pharmaceuticals Pipeline

DrugIndicationPhase
Ent001Type 1 Diabetes & Inflammatory Bowel Disease (Ulcerative Colitis)Phase 1
EbrasodebartAutoimmune Disorders (specifics not fully detailed)Preclinical or Early Clinical